# Minerals Technologies Inc: financial statements, quarterly MTX · NYSE · CIK 891014 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mtx.md) · [Financials](/companies/mtx/financials.md) · [Filings](/companies/mtx/filings.md) · [Insiders](/companies/mtx/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtx/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [548](/filings/0000891014-24-000116.md) | [525 d](/filings/0000891014-26-000067.md) | [535](/filings/0000891014-25-000045.md) | [541](/filings/0000891014-25-000124.md) | [525](/filings/0000891014-25-000162.md) | [518 d](/filings/0000891014-26-000067.md) | [492](/filings/0000891014-26-000108.md) | [529](/filings/0000891014-26-000167.md) | [532](/filings/0000891014-25-000162.md) | [520 d](/filings/0000891014-26-000067.md) | [547](/filings/0000891014-26-000108.md) | [548](/filings/0000891014-26-000167.md) | | Cost of revenue | $m | [415](/filings/0000891014-24-000116.md) | [399 d](/filings/0000891014-26-000067.md) | [399](/filings/0000891014-25-000045.md) | [397](/filings/0000891014-25-000124.md) | [390](/filings/0000891014-25-000162.md) | [385 d](/filings/0000891014-26-000067.md) | [372](/filings/0000891014-26-000108.md) | [392](/filings/0000891014-26-000167.md) | [395](/filings/0000891014-25-000162.md) | [395 d](/filings/0000891014-26-000067.md) | [416](/filings/0000891014-26-000108.md) | [415](/filings/0000891014-26-000167.md) | | Gross profit | $m | [133](/filings/0000891014-24-000116.md) | [125 d](/filings/0000891014-26-000067.md) | [136](/filings/0000891014-25-000045.md) | [144](/filings/0000891014-25-000124.md) | [135](/filings/0000891014-25-000162.md) | [133 d](/filings/0000891014-26-000067.md) | [120](/filings/0000891014-26-000108.md) | [137](/filings/0000891014-26-000167.md) | [137](/filings/0000891014-25-000162.md) | [125 d](/filings/0000891014-26-000067.md) | [131](/filings/0000891014-26-000108.md) | [134](/filings/0000891014-26-000167.md) | | Research and development | $m | [5.2](/filings/0000891014-24-000116.md) | [5.1 d](/filings/0000891014-26-000067.md) | [5.6](/filings/0000891014-25-000045.md) | [5.8](/filings/0000891014-25-000124.md) | [5.9](/filings/0000891014-25-000162.md) | [5.7 d](/filings/0000891014-26-000067.md) | [5.8](/filings/0000891014-26-000108.md) | [5.7](/filings/0000891014-26-000167.md) | [5.6](/filings/0000891014-25-000162.md) | [5.8 d](/filings/0000891014-26-000067.md) | [6.1](/filings/0000891014-26-000108.md) | [5.9](/filings/0000891014-26-000167.md) | | Selling, general and administrative | $m | [50.9](/filings/0000891014-24-000116.md) | [51.0 d](/filings/0000891014-26-000067.md) | [53.0](/filings/0000891014-25-000045.md) | [53.3](/filings/0000891014-25-000124.md) | [50.1](/filings/0000891014-25-000162.md) | [52.8 d](/filings/0000891014-26-000067.md) | [50.6](/filings/0000891014-26-000108.md) | [52.2](/filings/0000891014-26-000167.md) | [53.0](/filings/0000891014-25-000162.md) | [52.2 d](/filings/0000891014-26-000067.md) | [57.5](/filings/0000891014-26-000108.md) | [53.3](/filings/0000891014-26-000167.md) | | Operating income | $m | [(7.9)](/filings/0000891014-24-000116.md) | [66.8 d](/filings/0000891014-26-000067.md) | [75.2](/filings/0000891014-25-000045.md) | [50.6](/filings/0000891014-25-000124.md) | [76.6](/filings/0000891014-25-000162.md) | [84.1 d](/filings/0000891014-26-000067.md) | [(160)](/filings/0000891014-26-000108.md) | [74.6](/filings/0000891014-26-000167.md) | [70.9](/filings/0000891014-25-000162.md) | [62.0 d](/filings/0000891014-26-000067.md) | [58.7](/filings/0000891014-26-000108.md) | [(220)](/filings/0000891014-26-000167.md) | | Interest expense | $m | [15.3](/filings/0000891014-23-000103.md) | [15.2 d](/filings/0000891014-24-000014.md) | [14.9](/filings/0000891014-24-000039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(3.5)](/filings/0000891014-24-000116.md) | [9.2 d](/filings/0000891014-26-000067.md) | [13.9](/filings/0000891014-25-000045.md) | [15.6](/filings/0000891014-25-000124.md) | [13.7](/filings/0000891014-25-000162.md) | [16.2 d](/filings/0000891014-26-000067.md) | [(32.1)](/filings/0000891014-26-000108.md) | [13.9](/filings/0000891014-26-000167.md) | [13.5](/filings/0000891014-25-000162.md) | [9.6 d](/filings/0000891014-26-000067.md) | [9.9](/filings/0000891014-26-000108.md) | [(46.2)](/filings/0000891014-26-000167.md) | | Net income | $m | [(19.2)](/filings/0000891014-24-000116.md) | [39.7 d](/filings/0000891014-26-000067.md) | [46.7](/filings/0000891014-25-000045.md) | [19.7](/filings/0000891014-25-000124.md) | [46.7](/filings/0000891014-25-000162.md) | [54.0 d](/filings/0000891014-26-000067.md) | [(144)](/filings/0000891014-26-000108.md) | [45.4](/filings/0000891014-26-000167.md) | [43.0](/filings/0000891014-25-000162.md) | [37.2 d](/filings/0000891014-26-000067.md) | [36.2](/filings/0000891014-26-000108.md) | [(184)](/filings/0000891014-26-000167.md) | | Diluted EPS | $ per share | [(0.59)](/filings/0000891014-24-000116.md) | not reported | [1.44](/filings/0000891014-25-000045.md) | [0.61](/filings/0000891014-25-000124.md) | [1.45](/filings/0000891014-25-000162.md) | not reported | [(4.51)](/filings/0000891014-26-000108.md) | [1.44](/filings/0000891014-26-000167.md) | [1.37](/filings/0000891014-25-000162.md) | not reported | [1.17](/filings/0000891014-26-000108.md) | [(5.90)](/filings/0000891014-26-000167.md) | | Basic EPS | $ per share | [(0.59)](/filings/0000891014-24-000116.md) | not reported | [1.45](/filings/0000891014-25-000045.md) | [0.61](/filings/0000891014-25-000124.md) | [1.45](/filings/0000891014-25-000162.md) | not reported | [(4.51)](/filings/0000891014-26-000108.md) | [1.44](/filings/0000891014-26-000167.md) | [1.37](/filings/0000891014-25-000162.md) | not reported | [1.17](/filings/0000891014-26-000108.md) | [(5.90)](/filings/0000891014-26-000167.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [268](/filings/0000891014-23-000103.md) | [317](/filings/0000891014-25-000162.md) | [316](/filings/0000891014-24-000039.md) | [311](/filings/0000891014-24-000089.md) | [317](/filings/0000891014-24-000116.md) | [333](/filings/0000891014-26-000067.md) | [307](/filings/0000891014-25-000045.md) | [314](/filings/0000891014-25-000124.md) | [320](/filings/0000891014-25-000162.md) | [329](/filings/0000891014-26-000167.md) | [316](/filings/0000891014-26-000108.md) | [342](/filings/0000891014-26-000167.md) | | Current assets | $m | [1,094](/filings/0000891014-23-000103.md) | [1,099](/filings/0000891014-25-000018.md) | [1,101](/filings/0000891014-24-000039.md) | [1,114](/filings/0000891014-24-000089.md) | [1,141](/filings/0000891014-24-000116.md) | [1,131](/filings/0000891014-26-000067.md) | [1,136](/filings/0000891014-25-000045.md) | [1,173](/filings/0000891014-25-000124.md) | [1,173](/filings/0000891014-25-000162.md) | [1,156](/filings/0000891014-26-000167.md) | [1,156](/filings/0000891014-26-000108.md) | [1,184](/filings/0000891014-26-000167.md) | | Total assets | $m | [3,345](/filings/0000891014-23-000103.md) | [3,347](/filings/0000891014-26-000067.md) | [3,339](/filings/0000891014-24-000039.md) | [3,346](/filings/0000891014-24-000089.md) | [3,394](/filings/0000891014-24-000116.md) | [3,394](/filings/0000891014-26-000067.md) | [3,401](/filings/0000891014-25-000045.md) | [3,455](/filings/0000891014-25-000124.md) | [3,459](/filings/0000891014-25-000162.md) | [3,469](/filings/0000891014-26-000167.md) | [3,465](/filings/0000891014-26-000108.md) | [3,495](/filings/0000891014-26-000167.md) | | Current liabilities | $m | [474](/filings/0000891014-23-000103.md) | [457](/filings/0000891014-25-000018.md) | [442](/filings/0000891014-24-000039.md) | [454](/filings/0000891014-24-000089.md) | [464](/filings/0000891014-24-000116.md) | [398](/filings/0000891014-26-000067.md) | [600](/filings/0000891014-25-000045.md) | [603](/filings/0000891014-25-000124.md) | [592](/filings/0000891014-25-000162.md) | [555](/filings/0000891014-26-000167.md) | [543](/filings/0000891014-26-000108.md) | [829](/filings/0000891014-26-000167.md) | | Total liabilities | $m | [1,722](/filings/0000891014-23-000103.md) | [1,660](/filings/0000891014-25-000018.md) | [1,643](/filings/0000891014-24-000039.md) | [1,649](/filings/0000891014-24-000089.md) | [1,649](/filings/0000891014-24-000116.md) | [1,611](/filings/0000891014-26-000067.md) | [1,766](/filings/0000891014-25-000045.md) | [1,767](/filings/0000891014-25-000124.md) | [1,749](/filings/0000891014-25-000162.md) | [1,719](/filings/0000891014-26-000167.md) | [1,704](/filings/0000891014-26-000108.md) | [1,918](/filings/0000891014-26-000167.md) | | Long-term debt | $m | [918](/filings/0000891014-23-000103.md) | [911](/filings/0000891014-25-000018.md) | [904](/filings/0000891014-24-000039.md) | [898](/filings/0000891014-24-000089.md) | [895](/filings/0000891014-24-000116.md) | [960](/filings/0000891014-26-000067.md) | [960](/filings/0000891014-25-000045.md) | [959](/filings/0000891014-25-000124.md) | [958](/filings/0000891014-25-000162.md) | [955](/filings/0000891014-26-000167.md) | [954](/filings/0000891014-26-000108.md) | [953](/filings/0000891014-26-000167.md) | | Current portion of debt | $m | [14.4](/filings/0000891014-23-000103.md) | [18.0](/filings/0000891014-25-000018.md) | [21.4](/filings/0000891014-24-000039.md) | [24.7](/filings/0000891014-24-000089.md) | [28.2](/filings/0000891014-24-000116.md) | [6.5](/filings/0000891014-26-000067.md) | [6.6](/filings/0000891014-25-000045.md) | [6.6](/filings/0000891014-25-000124.md) | [6.5](/filings/0000891014-25-000162.md) | [6.3](/filings/0000891014-26-000167.md) | [6.2](/filings/0000891014-26-000108.md) | [6.0](/filings/0000891014-26-000167.md) | | Short-term borrowings | $m | [109](/filings/0000891014-23-000103.md) | [85.4](/filings/0000891014-25-000018.md) | [75.7](/filings/0000891014-24-000039.md) | [69.0](/filings/0000891014-24-000089.md) | [60.0](/filings/0000891014-24-000116.md) | [5.1](/filings/0000891014-26-000067.md) | [19.7](/filings/0000891014-25-000045.md) | [17.7](/filings/0000891014-25-000124.md) | [13.4](/filings/0000891014-25-000162.md) | [0.4](/filings/0000891014-26-000167.md) | [6.0](/filings/0000891014-26-000108.md) | [6.0](/filings/0000891014-26-000167.md) | | Shareholders' equity | $m | [1,589](/filings/0000891014-23-000103.md) | [1,652](/filings/0000891014-25-000018.md) | [1,661](/filings/0000891014-24-000039.md) | [1,663](/filings/0000891014-24-000089.md) | [1,706](/filings/0000891014-24-000116.md) | [1,747](/filings/0000891014-26-000067.md) | [1,598](/filings/0000891014-25-000045.md) | [1,654](/filings/0000891014-25-000124.md) | [1,675](/filings/0000891014-25-000162.md) | [1,713](/filings/0000891014-26-000167.md) | [1,728](/filings/0000891014-26-000108.md) | [1,545](/filings/0000891014-26-000167.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [59.1 d](/filings/0000891014-24-000116.md) | [95.3 d](/filings/0000891014-26-000067.md) | [55.9](/filings/0000891014-25-000045.md) | [50.1 d](/filings/0000891014-25-000124.md) | [60.0 d](/filings/0000891014-25-000162.md) | [70.4 d](/filings/0000891014-26-000067.md) | [(4.4)](/filings/0000891014-26-000108.md) | [62.9 d](/filings/0000891014-26-000167.md) | [70.9 d](/filings/0000891014-25-000162.md) | [64.3 d](/filings/0000891014-26-000067.md) | [32.1](/filings/0000891014-26-000108.md) | [63.0 d](/filings/0000891014-26-000167.md) | | Capital expenditure | $m | [25.1 d](/filings/0000891014-24-000116.md) | [22.5 d](/filings/0000891014-26-000067.md) | [16.5](/filings/0000891014-25-000045.md) | [20.2 d](/filings/0000891014-25-000124.md) | [24.7 d](/filings/0000891014-25-000162.md) | [28.1 d](/filings/0000891014-26-000067.md) | [18.3](/filings/0000891014-26-000108.md) | [29.1 d](/filings/0000891014-26-000167.md) | [27.3 d](/filings/0000891014-25-000162.md) | [32.4 d](/filings/0000891014-26-000067.md) | [23.1](/filings/0000891014-26-000108.md) | [27.2 d](/filings/0000891014-26-000167.md) | | Dividends paid | $m | [1.6 d](/filings/0000891014-24-000116.md) | [3.2 d](/filings/0000891014-26-000067.md) | [3.2](/filings/0000891014-25-000045.md) | [3.3 d](/filings/0000891014-25-000124.md) | [3.2 d](/filings/0000891014-25-000162.md) | [3.5 d](/filings/0000891014-26-000067.md) | [3.6](/filings/0000891014-26-000108.md) | [3.4 d](/filings/0000891014-26-000167.md) | [3.4 d](/filings/0000891014-25-000162.md) | [3.8 d](/filings/0000891014-26-000067.md) | [3.7](/filings/0000891014-26-000108.md) | [3.8 d](/filings/0000891014-26-000167.md) | | Share repurchases | $m | [0.0 d](/filings/0000891014-24-000116.md) | [14.2 d](/filings/0000891014-26-000067.md) | [15.0](/filings/0000891014-25-000045.md) | [19.6 d](/filings/0000891014-25-000124.md) | [22.8 d](/filings/0000891014-25-000162.md) | [6.2 d](/filings/0000891014-26-000067.md) | [11.5](/filings/0000891014-26-000108.md) | [19.0 d](/filings/0000891014-26-000167.md) | [17.0 d](/filings/0000891014-25-000162.md) | [11.0 d](/filings/0000891014-26-000067.md) | [5.4](/filings/0000891014-26-000108.md) | [1.7 d](/filings/0000891014-26-000167.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [32.6](/filings/0000891014-23-000103.md) | [32.5](/filings/0000891014-24-000039.md) | [32.6](/filings/0000891014-24-000089.md) | [32.5](/filings/0000891014-24-000116.md) | [32.4](/filings/0000891014-25-000045.md) | [32.4](/filings/0000891014-25-000124.md) | [32.3](/filings/0000891014-25-000162.md) | [31.9](/filings/0000891014-26-000108.md) | [31.6](/filings/0000891014-26-000167.md) | [31.3](/filings/0000891014-25-000162.md) | [31.0](/filings/0000891014-26-000108.md) | [31.1](/filings/0000891014-26-000167.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 31,128,762 at 2026-07-22, from the cover of the [10-Q filed 2026-07-31](/filings/0000891014-26-000167.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.